TCG Lifesciences Pvt. Limited (formerly “Chembiotek Research International”) is a leading global Contract Research and CDMO company delivering innovative R&D services in the areas of pharmaceutical, biotech and related industries. We started our operations in 2001 in Kolkata, India, and currently have our presence in the United States, Europe, and Japan.
TCGLS and its subsidiaries have a strong talent pool of more than 1,300 scientists, of which over 300 have PhDs and the balance hold master’s degrees; drawn from leading global academic institutions and industry. Our services span chemistry synthesis, in vitro and in vivo pharmacology, DMPK, analytical development and validation and data science. We offer specific/functional solutions to integrated projects across multiple therapeutic areas with a specific focus on Inflammation & Pain, Infectious Diseases, Central Nervous systems, and Oncology. Our infrastructure includes world-class chemistry and biology laboratories, AAALAC certified animal facility, electrophysiology laboratory, BSL 2 laboratory, and cGMP kilo labs and US FDA accredited manufacturing company.
Partner with global pharma and biotechnology companies and collaboratively discover new molecules to address the unmet medical needs. Collaborate with bio-medical researchers, research institutions and academia to accelerate generation of knowledge and leverage innovation and technology platforms.
We are a part of ‘The Chatterjee Group’ (TCG), a global investment conglomerate headquartered in New York with strategic investments of over USD 1 Billion. The group is established by Dr. Purnendu Chatterjee. TCG is internationally known for generating significant capital appreciation through long term strategic investments, both in the private and public sectors. Dr. Chattejee has made several strategic investments in India, particularly in knowledge intensive industries, such as Information Technology, IT enabled services, Life Sciences, Real Estate and Petrochemicals amongst others.